November 04, 2021

M&A Watch: ‘Mission Critical’ Board Oversight

订阅

Jump to...

 

M&A WATCH: ‘MISSION CRITICAL’ BOARD OVERSIGHT

Boeing decision suggests importance of board oversight over critical risks and operations in Caremark claims

On September 7, 2021, a Delaware court largely denied The Boeing Company’s (“Boeing”) motion to dismiss a stockholder derivative suit against Boeing directors in connection with two crashes of Boeing’s 737 MAX airplane in October 2018 and March 2019. In In re The Boeing Company Derivative Litigation, No. 2019-0907-MTZ (Del. Ch. Sept. 7, 2021), the plaintiffs alleged, among other things, that Boeing’s board of directors had breached its fiduciary duty of oversight under the standards established in In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996) and Marchand v. Barnhill, 212 A.3d 805 (Del. 2019) by failing to establish an adequate reporting system for airplane safety and “turning a blind eye to a red flag representing airplane safety problems”. Though noting that Caremark claims are “possibly the most difficult theory in corporate law upon which a plaintiff might hope to win a judgment,” Vice Chancellor Zurn of the Delaware Court of Chancery (the “Court”), denied the defendants’ motion to dismiss on the basis that the plaintiffs had adequately pled facts to support the claim that the directors had breached their duty of oversight.

Special thanks to associate Joon Lee who contributed to this publication.

Read the full memo, ‘Mission Critical’ Board Oversight.

Authors and Contributors

George Casey

合伙人

并购

+1 212 848 8787

+1 212 848 8787

纽约

Scott Petepiece

合伙人

并购

+1 212 848 8576

+1 212 848 8576

纽约

Alan S. Goudiss

合伙人

诉讼

+1 212 848 4906

+1 212 848 4906

纽约

Daniel Litowitz

合伙人

并购

+1 212 848 7784

+1 212 848 7784

纽约

Lona Nallengara

合伙人

资本市场

+1 212 848 8414

+1 212 848 8414

纽约

K. Mallory Brennan

合伙人

诉讼

+1 713 354 4847

+1 713 354 4847

+1 212 848 7657

+1 212 848 7657

休斯顿

Lara Aryani

合伙人

并购

+1 212 848 7556

+1 212 848 7556

纽约

Grace Jamgochian

合伙人

并购

+1 212 848 8393

+1 212 848 8393

纽约

Derrick Lott

合伙人

并购

+1 212 848 7421

+1 212 848 7421

纽约

Roger Morscheiser

合伙人

并购

+1 212 848 7422

+1 212 848 7422

纽约